BioCentury | May 14, 2020
Finance

May 13 Quick Takes: MyoKardia raises $551M; plus Legend looks to NASDAQ for IPO and ADC, Travecta, QureBio, Kintor, Lantern, Kiromic

...$25 million and be valued at $96.5 million. Cancer discovery company Kiromic seeks $20M IPO Kiromic Biopharma Inc....
...GT0918) Kintor Pharmaceuticals Ltd. MyoKardia Inc. ADC Therapeutics S.A. Travecta Therapeutics Pte. Ltd. Lantern Pharma Inc. Legend Biotechnology Co. Ltd. Androgen receptor QureBio Ltd. Kiromic Biopharma Inc....
Items per page:
1 - 1 of 1
BioCentury | May 14, 2020
Finance

May 13 Quick Takes: MyoKardia raises $551M; plus Legend looks to NASDAQ for IPO and ADC, Travecta, QureBio, Kintor, Lantern, Kiromic

...$25 million and be valued at $96.5 million. Cancer discovery company Kiromic seeks $20M IPO Kiromic Biopharma Inc....
...GT0918) Kintor Pharmaceuticals Ltd. MyoKardia Inc. ADC Therapeutics S.A. Travecta Therapeutics Pte. Ltd. Lantern Pharma Inc. Legend Biotechnology Co. Ltd. Androgen receptor QureBio Ltd. Kiromic Biopharma Inc....
Items per page:
1 - 1 of 1